■ 영문 제목 : Pharmaceutical Filtration Market by Product (Membrane, Depth filter), System (Single use, Reusable), Technique (Microfiltration, Nanofiltration), Application (API, Vaccine, Antibody), Scale of Operation (Manufacturing, Pilot, R&D) & Region - Global Forecasts to 2028 | |
![]() | ■ 상품코드 : BT4058-23 ■ 조사/발행회사 : MarketsandMarkets ■ 발행일 : 2023년 2월 ■ 페이지수 : 433 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 세계 ■ 산업 분야 : 의약품 |
Single User (1인 열람용) | USD4,950 ⇒환산₩6,682,500 | 견적의뢰/주문/질문 |
Five User (5인 열람용) | USD6,650 ⇒환산₩8,977,500 | 견적의뢰/주문/질문 |
Corporate License (동일 법인내 공유가능) | USD8,150 ⇒환산₩11,002,500 | 견적의뢰/구입/질문 |
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
MarketsandMarkets사의 본 보고서는 세계의 의약품 여과 시장 규모가 2023년에 135억 달러에 이르며, 2028년까지 262억 달러로 확대될 것으로 예상하고 있습니다. 덧붙여 예측 기간 동안 연평균 14.2%로 성장할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 의약품 여과 시장에 대해 조사하여, 소개, 조사 방법, 개요, 프리미엄 인사이트, 시장 개요, 제품별 (멤브레인, 시스템, 기타) 분석, 기술별 (정밀 여과, 나노 여과, 기타) 분석, 용도별 (최종 제품 가공, 원료 여과, 세포 분리, 수질 정화, 공기 정화) 분석, 종류별 (무균 여과, 비멸균 여과) 분석, 지역별 (북미, 유럽, 아시아 태평양, 중남미, 중동 및 아프리카) 분석, 경쟁 현황, 기업 정보 등의 내용을 게재하고 있습니다. 또한 본 보고서는 Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US) 등의 기업 정보를 포함하고 있습니다. · 소개 · 조사 방법 · 개요 · 프리미엄 인사이트 · 시장 개요 · 세계의 의약품 여과 시장 규모 : 제품별 - 멤브레인의 시장 규모 - 시스템의 시장 규모 - 기타 제품의 시장 규모 · 세계의 의약품 여과 시장 규모 : 기술별 - 정밀 여과 기술의 시장 규모 - 나노 여과 기술의 시장 규모 - 기타 기술의 시장 규모 · 세계의 의약품 여과 시장 규모 : 용도별 - 최종 제품 가공에 사용되는 의약품 여과에의 시장 규모 - 원료 여과에 사용되는 의약품 여과에의 시장 규모 - 세포 분리에 사용되는 의약품 여과에의 시장 규모 - 수질 정화에 사용되는 의약품 여과에의 시장 규모 - 공기 정화에 사용되는 의약품 여과에의 시장 규모 · 세계의 의약품 여과 시장 규모 : 종류별 - 무균 여과의 시장 규모 - 비멸균 여과의 시장 규모 · 세계의 의약품 여과 시장 규모 : 지역별 - 북미의 의약품 여과 시장 규모 - 유럽의 의약품 여과 시장 규모 - 아시아 태평양의 의약품 여과 시장 규모 - 중남미의 의약품 여과 시장 규모 - 중동 및 아프리카의 의약품 여과 시장 규모 · 경쟁 현황 · 기업 정보 |
“The pharmaceutical filtration market is expected to grow at a CAGR of 14.2% during the forecast period. ”
The market is estimated to be around USD 13.5 billion in 2023 and is projected to reach USD 26.2 billion by 2028. Growth in the pharmaceutical filtration market can be attributed to factors such as emerging countries like China, India, Brazil, and Mexico offering significant growth opportunities, advancement in nanofiber technology, and increased manufacturing and R&D in the pharmaceutical & biotechnology industries. On the other hand, membrane fouling and the growing capital investment required to set up new production facilities are expected to hinder market growth.
“In 2022 the systems segment accounted for the second largest share of the pharmaceutical market”
Based on products, the pharmaceutical filtration market is segmented into major three segments, namely, filters, systems, and other products. The filter market is further segmented into membrane filters, depth filters, and other filters, such as prefilters, bag filters, and magnetic filters. The systems market is further segmented into single-use systems and reusable systems. In 2022 the systems segment accounted for the second largest share of the pharmaceutical market. The large share of this segment can primarily be attributed rising importance of separation and purification applications. Developments in research techniques and increased demand for more specificity in the filtration process are increasing the adoption of single-use technologies in many small-scale biopharmaceutical processes.
“The ultrafiltration techniques accounted for the second largest market share of this market in 2022”
Based on technique, the pharmaceutical filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other techniques. The other techniques segment includes reverse osmosis and ion exchange. The microfiltration techniques accounted for the second largest market share of this market in 2022, and this can be primarily attributed to the implementation of ultrafiltration for cell harvesting and enzyme purification plasma separation. It is also used in the filtration of active pharmaceutical ingredients, media & buffers, formulations, and filling solutions. To a certain extent, UF allows the removal of viruses, phage, colloids, and macromolecules, which cannot be achieved with microfiltration and hence is acquiring large share in the market.
“The sterile filtration technique accounted for the largest market share of this market in 2022”
Based on type, the pharmaceutical filtration market is segmented into sterile filtration and non-sterile filtration. The sterile filtration technique accounted for the largest market share of this market in 2022, and this can be attributed the factors such as the fast growth of biologics, the rapid increase in the requirement of sterile filtration during the liquid processing of biopharmaceuticals, and the benefits of sterile filtration over non-sterile filtration.
Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US), Eaton Corporation plc (US), Donaldson Company, Inc. (US), Repligen Corporation (US), Porvair plc (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), Meissner Filtration Products, Inc. (US), Amazon Filters Ltd. (UK), Graver Technologies, LLC (US), MMS AG (Switzerland), MANN+HUMMEL International GmbH & Co. KG (Germany), ErtelAlsop (US), Kasag Swiss AG (Switzerland), Freudenberg Filtration Technologies SE & Co. KG (Germany), Cole-Parmer Instrument Company, LLC. (US), Cantel Medical Corp. (US), Filtrox AG (Switzerland), Saint-Gobain Performance Plastics (France), and Membrane Solutions (US) are some of the major players operating in the pharmaceutical filtration market.
“Asia Pacific: The fastest-growing region in the pharmaceutical filtration market”
The pharmaceutical filtration market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the growing incidence rate of viral diseases, the requirement to maintain a clean manufacturing environment because of strict foreign regulatory rules, the fast expansion of generics manufacturing, developments in nanofiber technologies, increasing R&D spending on biopharmaceutical projects, and the growth of the biotechnology industry in developing countries.
The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 80% and Demand Side – 20%
• By Designation: Managers- 45%, CXOs and Director level – 30%, and Executives – 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%
List of Companies Profiled in the Report:
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Sartorius AG (Germany)
• Parker-Hannifin Corporation (US)
• Thermo Fisher Scientific Inc. (US)
• 3M Company (US)
• Eaton Corporation plc (US)
• Donaldson Company, Inc. (US)
• Repligen Corporation (US)
• Porvair plc (UK)
• Alfa Laval Corporate AB (Sweden)
• Corning Incorporated (US)
• Meissner Filtration Products, Inc. (US)
• Amazon Filters Ltd. (UK)
• Graver Technologies, LLC (US)
• MMS AG (Switzerland)
• MANN+HUMMEL International GmbH & Co. KG (Germany)
• ErtelAlsop (US)
• Kasag Swiss AG (Switzerland)
• Freudenberg Filtration Technologies SE & Co. KG (Germany)
• Cole-Parmer Instrument Company, LLC. (US)
• Cantel Medical Corp. (US)
• Filtrox AG (Switzerland)
• Saint-Gobain Performance Plastics (France)
• Membrane Solutions (US)
Research Coverage:
This report provides a detailed picture of the pharmaceutical filtration market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical filtration market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.
1 INTRODUCTION 58 9.1 INTRODUCTION 217 TABLE 218 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 217 9.2 STERILE FILTRATION 217 9.2.1 ADVANTAGES OF STERILE FILTERS OVER NON-STERILE FILTERS TO DRIVE GROWTH 217 TABLE 219 GLOBAL STERILE FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 218 TABLE 220 NORTH AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 218 TABLE 221 EUROPE: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 218 TABLE 222 ASIA PACIFIC: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 219 TABLE 223 LATIN AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 219 9.3 NON-STERILE FILTRATION 219 9.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO PROMOTE MARKET GROWTH 219 TABLE 224 GLOBAL NON-STERILE FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 220 TABLE 225 NORTH AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 220 TABLE 226 EUROPE: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 221 TABLE 227 ASIA PACIFIC: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 221 TABLE 228 LATIN AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 222 10 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION 223 10.1 INTRODUCTION 224 TABLE 229 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 224 10.2 MANUFACTURING-SCALE OPERATION 224 10.2.1 GROWTH IN BIOLOGICS AND BIOSIMILARS MANUFACTURING TO DRIVE MARKET 224 TABLE 230 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY REGION, 2021–2028 (USD MILLION) 225 TABLE 231 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 226 TABLE 232 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 226 TABLE 233 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 227 TABLE 234 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 227 10.3 PILOT-SCALE OPERATION 227 10.3.1 INCREASED OUTSOURCING TO DRIVE MARKET GROWTH 227 TABLE 235 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY REGION, 2021–2028 (USD MILLION) 228 TABLE 236 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 228 TABLE 237 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 229 TABLE 238 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 229 TABLE 239 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 230 10.4 R&D-SCALE OPERATION 230 10.4.1 INCREASING INVESTMENTS IN R&D OF BIOLOGICS TO PROPEL GROWTH 230 TABLE 240 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY REGION, 2021–2028 (USD MILLION) 231 TABLE 241 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 231 TABLE 242 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 232 TABLE 243 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 232 TABLE 244 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 233 11 PHARMACEUTICAL FILTRATION MARKET, BY REGION 234 11.1 INTRODUCTION 235 TABLE 245 PHARMACEUTICAL FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 235 11.2 NORTH AMERICA 235 FIGURE 30 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT 236 TABLE 246 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 237 TABLE 247 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 237 TABLE 248 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 237 TABLE 249 NORTH AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 238 TABLE 250 NORTH AMERICA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 238 TABLE 251 NORTH AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 239 TABLE 252 NORTH AMERICA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 239 TABLE 253 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 239 TABLE 254 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 240 TABLE 255 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 240 TABLE 256 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 241 TABLE 257 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 241 TABLE 258 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 242 11.2.1 US 242 11.2.1.1 US to dominate North American market during forecast period 242 FIGURE 31 US TO DOMINATE DISTRIBUTION OF R&D COMPANIES (2022) 243 TABLE 259 US: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 243 TABLE 260 US: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 243 TABLE 261 US: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 244 TABLE 262 US: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 244 TABLE 263 US: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 245 TABLE 264 US: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 245 TABLE 265 US: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 245 TABLE 266 US: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 246 TABLE 267 US: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 246 TABLE 268 US: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 247 TABLE 269 US: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 247 TABLE 270 US: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 248 11.2.2 CANADA 248 11.2.2.1 Growing government support for expanding biologics manufacturing facilities to support market growth 248 TABLE 271 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 249 TABLE 272 CANADA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 249 TABLE 273 CANADA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 249 TABLE 274 CANADA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 250 TABLE 275 CANADA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 250 TABLE 276 CANADA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 250 TABLE 277 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 251 TABLE 278 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 251 TABLE 279 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 251 TABLE 280 CANADA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 252 TABLE 281 CANADA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 252 TABLE 282 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 253 11.2.3 NORTH AMERICA: RECESSION IMPACT 253 11.3 EUROPE 254 TABLE 283 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 254 TABLE 284 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 255 TABLE 285 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 255 TABLE 286 EUROPE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 255 TABLE 287 EUROPE: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 256 TABLE 288 EUROPE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 256 TABLE 289 EUROPE: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 256 TABLE 290 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 257 TABLE 291 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 257 TABLE 292 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 257 TABLE 293 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 258 TABLE 294 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 258 TABLE 295 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 259 11.3.1 GERMANY 259 11.3.1.1 Growing pharmaceutical R&D and manufacturing to drive market 259 TABLE 296 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 260 TABLE 297 GERMANY: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 260 TABLE 298 GERMANY: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 261 TABLE 299 GERMANY: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 261 TABLE 300 GERMANY: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 262 TABLE 301 GERMANY: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 262 TABLE 302 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 262 TABLE 303 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 263 TABLE 304 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 263 TABLE 305 GERMANY: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 264 TABLE 306 GERMANY: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 264 TABLE 307 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 265 11.3.2 UK 265 11.3.2.1 Increased R&D investment and government aid to boost market growth 265 TABLE 308 UK: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 266 TABLE 309 UK: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 266 TABLE 310 UK: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 266 TABLE 311 UK: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 267 TABLE 312 UK: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 267 TABLE 313 UK: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 267 TABLE 314 UK: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 268 TABLE 315 UK: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 268 TABLE 316 UK: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 268 TABLE 317 UK: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 269 TABLE 318 UK: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 269 TABLE 319 UK: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 270 11.3.3 FRANCE 270 11.3.3.1 Government investment in pharmaceutical industry to drive growth 270 TABLE 320 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 271 TABLE 321 FRANCE: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 271 TABLE 322 FRANCE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 272 TABLE 323 FRANCE: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 272 TABLE 324 FRANCE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 273 TABLE 325 FRANCE: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 273 TABLE 326 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 273 TABLE 327 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 274 TABLE 328 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 274 TABLE 329 FRANCE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 275 TABLE 330 FRANCE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 275 TABLE 331 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 276 11.3.4 ITALY 276 11.3.4.1 Investment in biotechnology R&D to boost market growth 276 TABLE 332 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 276 TABLE 333 ITALY: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 277 TABLE 334 ITALY: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 277 TABLE 335 ITALY: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 278 TABLE 336 ITALY: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 278 TABLE 337 ITALY: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 278 TABLE 338 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 279 TABLE 339 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 279 TABLE 340 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 279 TABLE 341 ITALY: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 280 TABLE 342 ITALY: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 280 TABLE 343 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 281 11.3.5 SPAIN 281 11.3.5.1 Expansion of biomanufacturing facilities to support market growth 281 TABLE 344 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 282 TABLE 345 SPAIN: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 282 TABLE 346 SPAIN: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 282 TABLE 347 SPAIN: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 283 TABLE 348 SPAIN: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 283 TABLE 349 SPAIN: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 283 TABLE 350 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 284 TABLE 351 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 284 TABLE 352 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 284 TABLE 353 SPAIN: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 285 TABLE 354 SPAIN: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 285 TABLE 355 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 286 11.3.6 REST OF EUROPE 286 TABLE 356 ROE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 287 TABLE 357 ROE: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 287 TABLE 358 ROE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 287 TABLE 359 ROE: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 288 TABLE 360 ROE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 288 TABLE 361 ROE: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 288 TABLE 362 ROE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 289 TABLE 363 ROE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 289 TABLE 364 ROE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 289 TABLE 365 ROE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 290 TABLE 366 ROE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 290 TABLE 367 ROE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 291 11.3.7 EUROPE: RECESSION IMPACT 291 11.4 ASIA PACIFIC 291 FIGURE 32 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT 292 TABLE 368 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 293 TABLE 369 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 293 TABLE 370 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 294 TABLE 371 ASIA PACIFIC: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 294 TABLE 372 ASIA PACIFIC: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 295 TABLE 373 ASIA PACIFIC: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 295 TABLE 374 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 295 TABLE 375 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 296 TABLE 376 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 296 TABLE 377 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 297 TABLE 378 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 297 TABLE 379 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 298 TABLE 380 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 298 11.4.1 CHINA 298 11.4.1.1 Shift from generic medicine to innovative drugs to drive market for advanced pharmaceutical filtration 298 TABLE 381 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 299 TABLE 382 CHINA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 299 TABLE 383 CHINA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 300 TABLE 384 CHINA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 300 TABLE 385 CHINA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 301 TABLE 386 CHINA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 301 TABLE 387 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 301 TABLE 388 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 302 TABLE 389 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 302 TABLE 390 CHINA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 303 TABLE 391 CHINA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 303 TABLE 392 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 304 11.4.2 JAPAN 304 11.4.2.1 Stringent regulatory guidelines to create need for advanced filtration products 304 TABLE 393 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 305 TABLE 394 JAPAN: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 305 TABLE 395 JAPAN: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 306 TABLE 396 JAPAN: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 306 TABLE 397 JAPAN: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 307 TABLE 398 JAPAN: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 307 TABLE 399 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 307 TABLE 400 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 308 TABLE 401 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 308 TABLE 402 JAPAN: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 309 TABLE 403 JAPAN: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 309 TABLE 404 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 310 11.4.3 INDIA 310 11.4.3.1 Government initiatives and competitive nature of Indian pharmaceutical market to drive growth 310 TABLE 405 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 311 TABLE 406 INDIA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 311 TABLE 407 INDIA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 311 TABLE 408 INDIA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 312 TABLE 409 INDIA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 312 TABLE 410 INDIA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 312 TABLE 411 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 313 TABLE 412 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 313 TABLE 413 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 313 TABLE 414 INDIA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 314 TABLE 415 INDIA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 314 TABLE 416 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 315 11.4.4 SOUTH KOREA 315 11.4.4.1 Increased export of drugs to affect market growth 315 TABLE 417 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 315 TABLE 418 SOUTH KOREA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 316 TABLE 419 SOUTH KOREA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 316 TABLE 420 SOUTH KOREA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 317 TABLE 421 SOUTH KOREA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 317 TABLE 422 SOUTH KOREA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 317 TABLE 423 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 318 TABLE 424 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 318 TABLE 425 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 319 TABLE 426 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 319 TABLE 427 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 320 TABLE 428 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 320 11.4.5 REST OF ASIA PACIFIC 320 TABLE 429 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 321 TABLE 430 ROAPAC: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 321 TABLE 431 ROAPAC: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 322 TABLE 432 ROAPAC: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 322 TABLE 433 ROAPAC: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 323 TABLE 434 ROAPAC: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 323 TABLE 435 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 323 TABLE 436 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 324 TABLE 437 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 324 TABLE 438 ROAPAC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 325 TABLE 439 ROAPAC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 325 TABLE 440 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 326 11.4.6 ASIA PACIFIC: RECESSION IMPACT 326 11.5 LATIN AMERICA 327 TABLE 441 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 327 TABLE 442 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 327 TABLE 443 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 328 TABLE 444 LATIN AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 328 TABLE 445 LATIN AMERICA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 329 TABLE 446 LATIN AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 329 TABLE 447 LATIN AMERICA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 329 TABLE 448 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 330 TABLE 449 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 330 TABLE 450 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 331 TABLE 451 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 331 TABLE 452 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 332 TABLE 453 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 332 11.5.1 BRAZIL 332 11.5.1.1 Growth of vaccine manufacturing to drive market 332 TABLE 454 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 333 TABLE 455 BRAZIL: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 333 TABLE 456 BRAZIL: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 334 TABLE 457 BRAZIL: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 334 TABLE 458 BRAZIL: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 335 TABLE 459 BRAZIL: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 335 TABLE 460 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 335 TABLE 461 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 336 TABLE 462 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 336 TABLE 463 BRAZIL: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 337 TABLE 464 BRAZIL: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 337 TABLE 465 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 338 11.5.2 REST OF LATIN AMERICA 338 TABLE 466 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 338 TABLE 467 ROLATAM: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 339 TABLE 468 ROLATAM: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 339 TABLE 469 ROLATAM: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 340 TABLE 470 ROLATAM: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 340 TABLE 471 ROLATAM: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 340 TABLE 472 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 341 TABLE 473 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 341 TABLE 474 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 341 TABLE 475 ROLATAM: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 342 TABLE 476 ROLATAM: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 342 TABLE 477 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 343 11.5.3 LATIN AMERICA: RECESSION IMPACT 343 11.6 MIDDLE EAST & AFRICA 344 11.6.1 SLOW AND EVOLVING BIOPHARMACEUTICAL INDUSTRY AND REGULATIONS TO HAMPER MARKET GROWTH 344 TABLE 478 MEA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 344 TABLE 479 MEA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 345 TABLE 480 MEA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 345 TABLE 481 MEA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 346 TABLE 482 MEA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 346 TABLE 483 MEA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 346 TABLE 484 MEA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 347 TABLE 485 MEA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 347 TABLE 486 MEA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 347 TABLE 487 MEA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 348 TABLE 488 MEA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 348 TABLE 489 MEA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 349 11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 349 12 COMPETITIVE LANDSCAPE 350 12.1 INTRODUCTION 350 12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 350 FIGURE 33 PHARMACEUTICAL FILTRATION MARKET: STRATEGIES ADOPTED 351 12.3 MARKET SHARE ANALYSIS 352 FIGURE 34 PHARMACEUTICAL FILTRATION MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2022) 352 TABLE 490 PHARMACEUTICAL FILTRATION MARKET: DEGREE OF COMPETITION 353 12.4 REVENUE ANALYSIS 354 FIGURE 35 REVENUE ANALYSIS FOR KEY COMPANIES (2020–2022) 354 12.5 COMPANY EVALUATION MATRIX 354 FIGURE 36 PHARMACEUTICAL FILTRATION MARKET: COMPANY EVALUATION MATRIX, 2022 355 12.5.1 STARS 356 12.5.2 EMERGING LEADERS 356 12.5.3 PERVASIVE PLAYERS 356 12.5.4 PARTICIPANTS 356 12.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 357 12.6.1 OVERALL FOOTPRINT OF COMPANIES (25 COMPANIES) 357 TABLE 491 FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET 357 12.6.2 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES) 358 TABLE 492 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET 358 12.6.3 TECHNIQUE FOOTPRINT OF COMPANIES (25 COMPANIES) 359 TABLE 493 TECHNIQUE FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET 359 12.6.4 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 360 TABLE 494 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET 360 12.7 COMPANY EVALUATION MATRIX: START-UPS/SMES 361 FIGURE 37 PHARMACEUTICAL FILTRATION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 361 12.7.1 PROGRESSIVE COMPANIES 362 12.7.2 STARTING BLOCKS 362 12.7.3 RESPONSIVE COMPANIES 362 12.7.4 DYNAMIC COMPANIES 362 12.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES 363 TABLE 495 PHARMACEUTICAL FILTRATION MARKET: DETAILED LIST OF KEY START-UPS/SMES 363 TABLE 496 PHARMACEUTICAL FILTRATION MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 364 12.9 COMPETITIVE SCENARIO AND TRENDS 364 12.9.1 PRODUCT LAUNCHES 364 TABLE 497 PHARMACEUTICAL FILTRATION MARKET: PRODUCT LAUNCHES, JANUARY 2019 TO JANUARY 2023 365 12.9.2 DEALS 366 TABLE 498 PHARMACEUTICAL FILTRATION MARKET: DEALS, JANUARY 2019 TO JANUARY 2023 366 12.9.3 EXPANSIONS 368 TABLE 499 PHARMACEUTICAL FILTRATION MARKET: EXPANSIONS, JANUARY 2019 TO JANUARY 2023 368 13 COMPANY PROFILES 370 13.1 KEY PLAYERS 370 (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 13.1.1 MERCK KGAA 370 TABLE 500 MERCK KGAA: BUSINESS OVERVIEW 370 FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2021) 371 13.1.2 DANAHER CORPORATION 376 TABLE 501 DANAHER CORPORATION: BUSINESS OVERVIEW 376 FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 377 13.1.3 SARTORIUS AG 384 TABLE 502 SARTORIUS AG: BUSINESS OVERVIEW 384 FIGURE 40 SARTORIUS AG: COMPANY SNAPSHOT (2021) 385 13.1.4 PARKER HANNIFIN CORPORATION 390 TABLE 503 PARKER HANNIFIN CORPORATION: BUSINESS OVERVIEW 390 FIGURE 41 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2022) 391 13.1.5 EATON CORPORATION PLC 394 TABLE 504 EATON CORPORATION PLC: BUSINESS OVERVIEW 394 FIGURE 42 EATON CORPORATION PLC: COMPANY SNAPSHOT (2021) 395 13.1.6 THERMO FISHER SCIENTIFIC, INC. 398 TABLE 505 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 398 FIGURE 43 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021) 399 13.1.7 3M COMPANY 403 TABLE 506 3M COMPANY: BUSINESS OVERVIEW 403 FIGURE 44 3M COMPANY: COMPANY SNAPSHOT (2021) 404 13.1.8 DONALDSON COMPANY, INC. 408 TABLE 507 DONALDSON COMPANY, INC.: BUSINESS OVERVIEW 408 FIGURE 45 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT (2022) 409 13.1.9 REPLIGEN CORPORATION 412 TABLE 508 REPLIGEN CORPORATION: BUSINESS OVERVIEW 412 FIGURE 46 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2021) 413 13.1.10 PORVAIR PLC 416 TABLE 509 PORVAIR PLC: BUSINESS OVERVIEW 416 FIGURE 47 PORVAIR PLC: COMPANY SNAPSHOT (2021) 417 13.1.11 ALFA LAVAL CORPORATE AB 420 TABLE 510 ALFA LAVAL CORPORATE AB: BUSINESS OVERVIEW 420 FIGURE 48 ALFA LAVAL CORPORATE AB: COMPANY SNAPSHOT (2021) 421 13.1.12 CORNING INCORPORATED 424 TABLE 511 CORNING INCORPORATED: BUSINESS OVERVIEW 424 FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2021) 425 13.1.13 MEISSNER FILTRATION PRODUCTS, INC. 427 TABLE 512 MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW 427 13.1.14 AMAZON FILTERS LTD. 430 TABLE 513 AMAZON FILTERS LTD.: BUSINESS OVERVIEW 430 13.1.15 GRAVER TECHNOLOGIES, LLC. 433 TABLE 514 GRAVER TECHNOLOGIES, LLC.: BUSINESS OVERVIEW 433 13.2 OTHER COMPANIES 435 13.2.1 MMS AG 435 13.2.2 MANN+HUMMEL INTERNATIONAL GMBH & CO. KG 436 13.2.3 ERTELALSOP 437 13.2.4 KASAG SWISS AG 438 13.2.5 FREUDENBERG FILTRATION TECHNOLOGIES SE & CO. KG 439 13.2.6 COLE-PARMER INSTRUMENT COMPANY, LLC 440 13.2.7 CANTEL MEDICAL CORP. 441 13.2.8 FILTROX AG 442 13.2.9 SAINT-GOBAIN PERFORMANCE PLASTICS 443 13.2.10 MEMBRANE SOLUTIONS 444 *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 14 APPENDIX 445 14.1 DISCUSSION GUIDE 445 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 450 14.3 CUSTOMIZATION OPTIONS 452 14.4 RELATED REPORTS 453 14.5 AUTHOR DETAILS 454 |
※본 조사보고서 [세계의 의약품 여과 시장 (~2028년) : 제품별 (멤브레인, 심층 필터), 시스템별 (일회용, 재사용), 기술별 (정밀여과, 나노여과), 용도별 (API, 백신, 항체), 사업 규모별 (제조, 파일럿, R&D), 지역별] (코드 : BT4058-23) 판매에 관한 면책사항을 반드시 확인하세요. |
※본 조사보고서 [세계의 의약품 여과 시장 (~2028년) : 제품별 (멤브레인, 심층 필터), 시스템별 (일회용, 재사용), 기술별 (정밀여과, 나노여과), 용도별 (API, 백신, 항체), 사업 규모별 (제조, 파일럿, R&D), 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요. |